insights_auto
Why is EDIT down 3,01%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,77 US$
arrow_downward
-3,01%(-0,055) 1D
1,83 US$
arrow_upward
+3,39% (+0,060)todayPre-market
Closed: 18 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 US$
High
1,94 US$
Low
1,76 US$
Mkt. cap
272,43 მლნ.
Avg. vol.
2,39 მლნ.
Volume
24,03 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,86 US$
High
1,94 US$
Low
1,76 US$
Mkt. cap
272,43 მლნ.
Avg. vol.
2,39 მლნ.
Volume
24,03 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
24/7 Wall St.
·
57 წუთის წინ
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
BigGo Finance
·
2 საათის წინ
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
MarketWatch
·
12 წუთის წინ
Stock Market Today: Nasdaq to lead Dow and S&P 500 higher as tech rallies on Anthropic IPO optimism; Nvidia stock gains; Walmart earnings on tap: live updates
JournalArta
·
1 საათის წინ
Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc